Pharm Exec1h
FDA Approves Eli Lilly’s Omvoh for Crohn Disease
Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and ...
Pharm Exec4h
Cigna Expands Access to Fertility and Family-Building Benefits
A new offering in collaboration with Progyny, Inc makes fertility/family-building services more accessible and equitable.
Pharm Exec5h
Engaging Patients: Why Pharma’s Direct-to-Patient Approach Should Be Applauded
Pharmaceutical companies’ direct-to-patient (DTP) programs have recently sparked conversations and criticism in fear of their ...
Pharm Exec23h
Johnson & Johnson Initiates New Drug Application for TAR-200 in BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer
The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% ...